Get started
CRISPR THERAPEUTICS AG COM CHF0.03CRISPR THERAPEUTICS AG COM CHF0.03CRISPR THERAPEUTICS AG COM CHF0.03

CRISPR THERAPEUTICS AG COM CHF0.03

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0VRQ trade ideas

CRISPR - Long Term OutlookCrispr is still on the rise and trading within it's rising channel. It looks like it has completed a 5th wave and is due for a correction. There is major support around $73.00 which is also the 61.8% fib level. This may present a nice buying opportunity if it drops to around $73.00 and that support holds up. I think gene editing and genetic engineering will continue to have positive momentum until at least November. Disclaimer: This is not financial advice. Do your own research and due diligence. Good Luck!
NASDAQ:CRSP
by ChrisPtaco_32
1
LINK and CRSP similar structureLINK and CRSP have very similar looking charts of a long term ascending triangle breakout that quickly occurred relative to the total length of the triangle. Both have strong fundamentals, each having their place in the 4th industrial revolution. CRSP is on a 2.2x slower timescale than LINK, so LINK may be able to foreshadow price targets on CRSP. Fib extension of denoting the triangle breakout level to be 38.2% of the projected peak, says that LINK may hit ~$10 (agreeing with the previous LINK and ETH comparison) in 2020 which would infer that CRSP could reach ~$140 by late 2020-2021.
NASDAQ:CRSPLong
by thunder_clef
1
C & HIf you look back to 2019 there is a prior high at the top of a wick of $74 that appears to be a shooting star on the weekly time frame. So hypothetically entry would be over that high at 74.10 (ish) (stock is overbought on daily) Stop: Under handle low which is under 57.50 (ish) A bit of a wide stop )o: Target 1: 90 to 99 Target 2: 127 to 140 I am waiting on the breakout on this one since it is so close to it today and the stock in overbought. Also the prior high was not solid in my opinion, but I like the stock Biotech is hot right now but in the past, a very risky sector..this is just an observation..so be safe!
NASDAQ:CRSPLong
by lauralea
1
PANDEMIA FACINGThis Company engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA . CRSP and Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society. The company itself still seems to manage and operates even we're facing crisis e.g. The COVID-19 pandemic.
NASDAQ:CRSPLong
by lyriccal12
1